A mouse model for Finnish variant late infantile neuronal ceroid lipofuscinosis, CLN5, reveals neuropathology associated with early aging

Human Molecular Genetics

Volumn 13, Issue 23, 2004, Pages 2893-2906

  Kopra, Outi ^a   Vesa, Jouni ^b   von Schantz, Carina ^a   Manninen, Tuula ^a,b   Minye, Helena ^b   Fabritius, Anna Liisa ^a,b   Rapola, Juhani ^a   van Diggelen, Otto P ^c   Saarela, Janna ^a   Jalanko, Anu ^a   Peltonen, Leena ^a,b  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN PROTEIN; MYELIN; PROTEIN CLN5; UNCLASSIFIED DRUG;

AGING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOFLUORESCENCE; BRAIN ATROPHY; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DEMYELINATION; DISEASE ASSOCIATION; DISEASE COURSE; DNA FINGERPRINTING; DOWN REGULATION; ELECTRON MICROSCOPY; EXON; GABAERGIC SYSTEM; GENE DELETION; GENE EXPRESSION PROFILING; GENETIC TRANSCRIPTION; IMMUNE RESPONSE; IMMUNITY; INTERNEURON; MOUSE; NERVE DEGENERATION; NEURONAL CEROID LIPOFUSCINOSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SYMPTOMATOLOGY; ULTRASTRUCTURE; UNINDEXED SEQUENCE; VISUAL IMPAIRMENT;

AGING; ANIMALS; BASE SEQUENCE; BRAIN; DISEASE MODELS, ANIMAL; DNA PRIMERS; GAMMA-AMINOBUTYRIC ACID; GENE EXPRESSION PROFILING; HUMANS; IMMUNOHISTOCHEMISTRY; LYSOSOMES; MEMBRANE PROTEINS; MICE; MICE, KNOCKOUT; NEURONAL CEROID-LIPOFUSCINOSES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 9744278990     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/ddh312     Document Type: Article

References (41)

1. Hofmann, S.L. and Peltonen, L. (2001) The neuronal ceroid lipofuscinoses. In Scriver, C.R., Beaudet, A.L., Sly, W.S. and Valle, D. (eds), The Metabolic and Molecular Base of Inherited Disease. McGraw-Hill Companies Inc., USA, Vol. 3, pp. 3877-3894.
2. Santavuori, P., Rapola, J., Haltia, M., Tyynelä, J., Peltonen, L. and Mole, S. (1999) CLN5. Finnish variant late infantile NCL. In Goebel, H.H., Mole, S.E. and Lake, B.D. (eds), The Neuronal Ceroid Lipofuscinoses (Batten Disease). IOS Press, Amsterdam, Vol. 33, pp. 91-97.
3. Tyynelä, J., Suopanki, J., Santavuori, P., Baumann, M. and Haltia, M. (1997) Variant late infantile neuronal ceroid-lipofuscinosis: pathology and biochemistry. J Neuropathol. Exp. Neurol., 56, 369-375.
4. Savukoski, M., Kestilä, M., Williams, R., Järvelä, I., Sharp, J., Harris, J., Santavuori, P., Gardiner, M. and Peltonen, L. (1994) Defined chromosomal assignment of CLN5 demonstrates that at least four genetic loci are involved in the pathogenesis of human ceroid lipofuscinoses. Am. J Hum. Genet., 55, 695-701.
5. Savukoski, M., Klockars, T., Holmberg, V., Santavuori, P., Lander, E.S. and Peltonen, L. (1998) CLN5, a novel gene encoding a putative transmembrane protein mutated in Finnish variant late infantile neuronal ceroid lipofuscinosis. Nat. Genet., 19, 286-288.
6. Holmberg, V., Lauronen, L., Autti, T., Santavuori, P., Savukoski, M., Uvebrant, P., Hofmann, I., Peltonen, L. and Jä rvelä I. (2000) Phenotype-genotype correlation in eight patients with Finnish variant late infantile NCL (CLN5). Neurology, 22, 579-581.
7. Isosomppi, J., Vesa, J., Jalanko, A. and Peltonen, L. (2002) Lysosomal localization of the neuronal ceroid lipofuscinosis CLN5 protein. Hum. Mol. Genet., 15, 885-891.
8. Vesa, J., Chin, M.H., Oelgeschlager, K., Isosomppi, J., DellAngelica, E.C., Jalanko, A. and Peltonen, L. (2002) Neuronal ceroid lipofuscinoses are connected at molecular level: interaction of CLN5 protein with CLN2 and CLN3. Mol. Biol. Cell., 13, 2410-2420.
9. Gupta, P., Soyombo, A.A., Atashband, A., Wisniewski, K.E., Shelton, J.M., Richardson, J.A., Hammer, R.E. and Hofmann, S.L. (2001) Disruption of PPT1 or PPT2 causes neuronal ceroid lipofuscinosis in knockout mice. Proc. Natl Acad. Sci. USA, 98, 13566-13571.
10. Mitchison, H.M., Bernard, D.J., Greene, N.D., Cooper, J.D., Junaid, M.A., Pullarkat, R.K., de Vos, N., Breuning, M.H., Owens, J.W., Mobley, W.C. et al. (1999) Targeted disruption of the Cln3 gene provides a mouse model for Batten disease. The Batten Mouse Model Consortium [corrected]. Neurobiol. Dis., 6, 321-334.
11. Katz, M.L., Shibuya, H., Liu, P.C., Gao, C.L. and Johnson, G.S. (1999) A mouse gene knockout model for juvenile ceroid-lipofuscinosis (Batten disease). J. Neurosci. Res., 57 551-556.
12. Cotman, S.L., Vrbanac, V., Lebel, L.A., Lee, R.L., Johnson, K.A., Donahue, L.R., Teed, A.M., Antonellis, K., Bronson, R.T., Lerner, T.J. et al. (2002) Cln3(Deltaex7/8) knock-in mice with the common JNCL mutation exhibit progressive neurologic disease that begins before birth. Hum. Mol. Genet., 11, 2709-2721.
13. Bronson, R.T., Donahue, L.R., Johnson, K.R., Tanner, A., Lane, P.W. and Faust, JR. (1998) Neuronal ceroid lipofuscinosis (nclf), a new disorder of the mouse linked to chromosome 9. Am. J. Med. Genet. 77, 289-297.
14. Bronson, R.T., Lake, B.D., Cook, S., Taylor, S. and Davidson, M.T. (1993) Motor neuron degeneration of mice is a model of neuronal ceroid lipofuscinosis (Batten's disease). Ann. Neurol., 33, 381-385.
15. Messer, A. and Plummer, J. (1993) Accumulating autofluorescent material as a marker for early changes in the spinal cord of the Mnd mouse. Neuromuscul. Disord., 3, 129-134.
16. Rogers, D.C., Fisher, E.M.C., Brown, S.D.M., Peters, J., Hunter, A.J. and Martin, J.E. (1997) Behavioral and functional analysis of mouse phenotype: SHIRPA, a proposed protocol for comprehensive phenotype assessment. Mamm. Genome, 8, 711-713.
17. Autti, T., Raininko, R., Launes, J., Nuutila, A. and Santavuori, P. (1992) Jansky-Bielschowsky variant disease: CT, MRI, and SPECT findings. Pediatr. Neurol., 8, 121-126.
18. Williams, R.S., Loft, I.T., Ferrante, R.J. and Caviness, V.S. (1977) The cellular pathology of neuronal ceroid lipofuscinosis. Arch. Neurol., 34, 298-305.
19. Braak, H. and Goebel H.H. (1978) Loss of pigment-laden stellate cells: a severe alteration of the isocortex in juvenile neuronal ceroid lipofuscinosis. Acta Neuropathol. (Berl.), 42, 53-57.
20. Braak, H. and Goebel, H.H. (1979) Pigmentoarchitectonic pathology of the isocortex in juvenile neuronal ceroid lipofuscinosis: axonal enlargements in layer IIIab and cell loss in layer V. Acta Neuropathol. (Berl.), 46, 79-83.
21. Bertamini, M., Marzani, B., Guarneri, R., Guarneri, P., Bigini, P., Mennini, T. and Curti, D. (2002) Mitochondrial oxidative metabolism in motor neuron degeneration (mnd) mouse central nervous system. Eur. J Neurosci., 16, 2291-2296.
22. March, P.A., Wurzelmann, S. and Walkley, S.U. (1995) Morphological alterations in neocortical and cerebellar GABAergic neurons in a canine model of juvenile Batten disease. Am. J. Med. Genet., 57, 204-212.
23. Cooper, J.D., Messer, A., Feng, A.K., Chua-Couzens, J. and Mobley, W.C. (1999) Apparent loss and hypertrophy of interneurons in a mouse model of neuronal ceroid lipofuscinosis: evidence for partial response to insulin-like growth factor-1 treatment. J. Neurosci., 19, 2556-2567.
24. Cooper, J.D. (2003) Progress towards understanding the neurobiology of Batten disease or neuronal ceroid lipofuscinosis. Curr. Opin. Neurol., 16, 121-128.
25. The Gene Ontology Consortium (2000) Gene ontology: tool for the unification of biology. Nature Genet., 25, 25-29.
26. Mennini, T., Bigini, P., Ravizza, T., Vezzani, A., Calvaresi, N., Tortarolo, M. and Bendotti, C. (2002) Expression of glutamate receptor subtypes in the spinal cord of control and mud mice, a model of motor neuron disorder. J. Neurosci. Res., 15, 553-560.
27. Elshatory, Y., Brooks, A.I., Chattopadhyay, S., Curran, T.M., Gupta, P., Ramalingam, V., Hofmann, S.L. and Pearce, D.A. (2003) Early changes in gene expression in two models of Batten disease. FEBS Lett. 13, 207-212.
28. Myerowitz, R., Lawson, D., Mizukami, H., Mi, Y., Tifft, C.J. and Proia, R.L. (2002) Molecular pathophysiology in Tay-Sachs and Sandhoff diseases as revealed by gene expression profiling. Hum. Mol. Genet., 15, 1343-1350.
29. Aisen, P.S. (2002) Anti-inflammatory agents in Alzheimer's disease. Curr. Neurol. Neurosci. Rep., 2, 405-409.
30. Beal, M.F. (2003) Mitochondria, oxidative damage, and inflammation in Parkinson's disease. Ann. NY Acad. Sci., 991, 120-131.
31. Carson, M.J. (2002) Microglia as liaisons between the immune and central nervous systems: functional implications for multiple sclerosis. Glia, 40, 218-231.
32. Saha, R.N. and Pahan, K. (2003) Tumor necrosis factor-alpha at the crossroads of neuronal life and death during HIV-associated dementia. J. Neurochem., 86, 1057-1071.
33. Becker, K.J. (1998) Inflammation and acute stroke. Curr. Opin. Neurol., 11, 45-49.
34. Tarkowski, E. (2002) Cytokines in dementias. Curr. Drug Targets Inflamm. Allergy, 1, 193-200.
35. Mootha, V.K., Lindgren, C.M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstå le, M., Laurila, E. et al. (2003) PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat. Genet., 34, 267-273.
36. Lee, C.-K., Weindruch, R. and Prolla, T. (2000) Gene-expression profile of the ageing brain in mice. Nat. Genet., 25, 294-297.
37. Wada, R., Tifft, C.J. and Proia, R.L. (2000) Microglial activation precedes acute neurodegeneration in Sandhoff disease and is suppressed by bone marrow transplantation. PNAS, 26, 10954-10959.
38. Finch, C.E. and Roth, G.S. (1999) In Seigel, G., Agranoff, J.B., Albers, W.R.W., Fisher, S.K. and Uhler, M.D. (eds), Basic Neurochemistry. Lippincott-Raven, Philadelphia, pp. 613-633.
39. Heinonen, O., Kyttälä, A., Lehmus, E., Paunio, T., Peltonen, L. and Jalanko, A. (2000) Expression of palmitoyl protein thioesterase in neurons. Mol. Gen. Metab., 69, 123-129.
40. van Diggelen, O.P., Keulemans, J.L.M., Kleijer, W.J., Thobois, S., Tilikete, C. and Voznyi, Y.V. (2001) Pre- an postnatal enzyme analysis for infantile, late infantile and adult neuronal ceroid lipofuscinosis (CLN1 and CLN2). Eur. J. Pediatr. Neurol., 5, 189-192.
41. Hämäläinen, H.K., Tubman, J.C., Vikman, S., Kyrölä, T., Ylikoski, E., Warrington, J.A. and Lahesmaa, R. (2001) Identification and validation of endogenous reference genes for expression profiling of T helper cell differentiation by quantitative real time RT-PCR. Anal. Biochem., 299, 63-70.